Author:
Narducci M G,Arcelli D,Picchio M C,Lazzeri C,Pagani E,Sampogna F,Scala E,Fadda P,Cristofoletti C,Facchiano A,Frontani M,Monopoli A,Ferracin M,Negrini M,Lombardo G A,Caprini E,Russo G
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference34 articles.
1. Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H et al. (eds) WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer Press: Lyon, France, 2008.
2. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713–1722.
3. Prince HM, Whittaker S, Hoppe RT . How I treat mycosis fungoides and Sezary syndrome. Blood 2009; 114: 4337–4353.
4. van Doorn R, Dijkman R, Vermeer MH, Out-Luiting JJ, van der Raaij-Helmer EM, Willemze R et al. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res 2004; 64: 5578–5586.
5. Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, van Voorst Vader PC et al. Novel and highly recurrent chromosomal alterations in Sezary syndrome. Cancer Res 2008; 68: 2689–2698.
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献